Multiplex Array Technology for Rapid COVID-19 Clade Variant Testing

A rapid, affordable adaptive surveillance test to screen for CoV-2 clade variants

As the SARS-CoV-2 virus evolves, mutations in the CoV-2 genome can increase the risk of false negative results in any of the existing molecular tests. With several variant strains circulating in the population—including some with increased transmissibility—and the potential for more to emerge, there is an urgent need for diagnostic tools which can accurately detect any clade variant (i.e., show 100 percent inclusivity), and distinguish clade variants from each other.

Download this white paper to learn about a real-time surveillance test to screen for CoV-2 clade variants, courtesy of PathogenDx.